エラストマー輸液ポンプ市場レポート：2030年までの動向、予測、競合分析

エラストマー輸液ポンプの動向と予測

世界のエラストマー輸液ポンプ市場の将来は、病院と外来手術センター市場に機会がありそうです。世界のエラストマー輸液ポンプ市場は、2024年から2030年にかけてCAGR 4.7%で成長すると予測されています。この市場の主な促進要因は、座りっぱなしのライフスタイルによるがん罹患率の増加、喫煙・飲酒者の割合の増加、使い捨ての小型外来ポンプの採用率の上昇です。

• Lucintel社は、用途別では疼痛管理が予測期間中に最も高い成長を遂げると予測しています。
• エンドユース別では、病院が高い成長を遂げると予測されています。
• 地域別では、慢性疾患の有病率の上昇と外科的介入の頻度の増加により、北米が予測期間中に最も高い成長が見込まれます。

エラストマー輸液ポンプ市場の戦略的成長機会

エラストマー輸液ポンプ市場は、さまざまな用途においていくつかの戦略的成長機会を提示しています。これらの機会は、技術の進歩や進化するヘルスケアニーズの影響を受けています。

• 技術統合：エラストマー輸液ポンプをEHRやモバイルアプリなどのデジタルヘルス技術と統合する大きな機会があります。この統合により、データの正確性、患者のモニタリング機能、リアルタイムのコミュニケーションが向上し、ヘルスケア業界における転帰の改善と業務の合理化につながります。
• 特定の治療に対するカスタマイズ：化学療法や疼痛管理など、特定の治療に合わせてエラストマー輸液ポンプをカスタマイズすることは、大きな成長機会となります。カスタマイズすることで効能をよりコントロールできるようになり、こうした専門分野における多様な治療ニーズに対応できるようになります。
• 新興市場への進出：新興市場で費用対効果の高いエラストマー輸液ポンプを普及させることは、大きな成長機会となります。手頃な価格と現地のヘルスケアニーズに対応することで、企業は市場への浸透を高め、これらの地域の新たな患者集団にリーチすることができます。
• 持続可能性の重視：エラストマー輸液ポンプの製造に持続可能性を取り入れることは、新たな機会です。これには、環境にやさしい材料の使用や製造工程が含まれ、世界の環境目標に合致し、環境意識の高い消費者や規制当局にアピールすることができます。
• 安全機能の強化：投与エラー低減システムやリアルタイムモニタリングなどの高度な安全システムに投資することは、患者の安全性と機器の信頼性に関する高まる基準を満たす戦略的機会を提供します。このような改良は、競争市場において製品を差別化し、ヘルスケアの本質的な問題に対処する上でも役立ちます。

こうした成長機会は、さまざまなヘルスケア環境におけるエラストマー輸液ポンプの用途拡大を反映しています。在宅ヘルスケア、慢性疾患管理、腫瘍学、小児医療、救急医療に注力することで、企業はこうした機会を活用して市場拡大を推進し、多様な患者のニーズに応えることができます。

エラストマー輸液ポンプ市場の促進要因・課題

エラストマー輸液ポンプ市場の主な促進要因・課題は、市場力学、患者の安全性への懸念、規制上の問題、コストへの配慮、技術の進歩などです。市場の複雑さを乗り越え、改善・成長する方法を見つけるには、これらすべての要素を考慮する必要があります。

市場成長の促進要因：

• 技術の進歩：デジタルヘルス技術とスマートデバイスの進化が新たな成長機会を生み出しています。例えば、ポンプをEHRやモバイルアプリと接続することで患者のモニタリングが強化され、治療がより効果的かつ個別化されます。
• 在宅ヘルスケア需要の増加：在宅ヘルスケアサービスに対するニーズの高まりが、ポータブルで使いやすいエラストマー輸液ポンプの需要を後押ししています。これらの機器により、病院の敷地外での治療が可能になり、入院期間が短縮され、患者の利便性が向上します。
• 患者の安全性の重視：患者の安全性が重視されるようになり、投薬ミスを減らす努力も相まって、エラストマー輸液ポンプの高度な安全機能の開発が推進されています。これらの機構は規制基準に合致しているため、ケアの質が向上しています。
• 慢性疾患の蔓延：糖尿病やがんなどの慢性疾患の罹患率の高さは、信頼性の高い輸液システムの需要を引き続き押し上げています。エラストマー輸液ポンプは、長期的な治療を提供し、さまざまな慢性疾患の治療をサポートするために不可欠です。
• 規制上のサポート：規制機関による実際のエビデンスの活用は、医療機器の高い基準を維持しながら、技術革新と市場の成長を促します。規制ガイドラインにより、医療機器の品質と安全性が標準化されます。

エラストマー輸液ポンプ市場の課題

• 高コスト：エラストマー輸液ポンプのコストは、特に価格に敏感な市場において、普及の妨げになる可能性があります。これに対処するためには、コストを管理し、購入しやすい価格に改善する努力が必要です。
• データセキュリティへの懸念：デジタル統合が進むにつれ、データセキュリティと患者のプライバシー保護が重要な課題となります。これらのリスクを軽減するためには、規制の遵守と強固なセキュリティ対策の実施が必要です。
• 規制遵守の複雑さ：複雑な規制、特に地域によって異なる要件に対応することは、圧倒される可能性があります。多様な基準を満たすことは、市場参入を遅らせ、承認プロセスで発生するコストを増加させる可能性があります。

エラストマー輸液ポンプ市場は、技術の進歩、在宅ケアソリューションの需要増加、慢性疾患の蔓延、規制当局の支援、研究開発への旺盛な投資といった重要な要因によって牽引されています。しかし、規制上のハードル、高い製造コスト、激しい市場競争などの課題は、市場のダイナミクスに影響を与えます。市場促進要因・課題のバランスを取ることは、市場企業が成長を促進し、製品提供を強化し、進化するヘルスケア提供の展望を切り開く上で極めて重要です。

目次

第1章 エグゼクティブサマリー

第2章 世界のエラストマー輸液ポンプ市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界のエラストマー輸液ポンプ市場の動向（2018～2023年）と予測（2024～2030年）
• エラストマー輸液ポンプの世界市場：製品別
  • 連続速度エラストマー輸液ポンプ
  • 可変速度エラストマー輸液ポンプ
• エラストマー輸液ポンプの世界市場：最終用途別
  • 病院
  • 外来手術センター
  • その他
• エラストマー輸液ポンプの世界市場：用途別
  • 疼痛管理
  • 化学療法
  • キレート療法
  • その他

第4章 2018年から2030年までの地域別市場動向と予測分析

• 地域別エラストマー輸液ポンプの世界市場
• 北米のエラストマー輸液ポンプ市場
• 欧州のエラストマー輸液ポンプ市場
• アジア太平洋地域のエラストマー輸液ポンプ市場
• その他地域のエラストマー輸液ポンプ市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界のエラストマー輸液ポンプ市場の製品別成長機会
  • 世界のエラストマー輸液ポンプ市場の最終用途別成長機会
  • 世界のエラストマー輸液ポンプ市場の用途別成長機会
  • 世界のエラストマー輸液ポンプ市場の地域別成長機会
• 世界のエラストマー輸液ポンプ市場の新たな動向
• 戦略分析
  • 新製品開発
  • 世界のエラストマー輸液ポンプ市場の能力拡大
  • 世界のエラストマー輸液ポンプ市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Ambu
• Avanos Medical
• Baxter
• B. Braun Melsungen
• Werfenlife
• Nipro
• Woo Young Medical
• Epic Medical
• Daiken Medical
• Smiths Medical

Elastomeric Infusion Pump Trends and Forecast

The future of the global elastomeric infusion pump market looks promising with opportunities in the hospital and ambulatory surgical center markets. The global elastomeric infusion pump market is expected to grow with a CAGR of 4.7% from 2024 to 2030. The major drivers for this market are increased cancer incidence due to sedentary lifestyles, a growing proportion of people who smoke and drink, as well as, rising adoption of small disposable ambulatory pumps.

• Lucintel forecasts that, within the application category, pain management is expected to witness the highest growth over the forecast period.
• Within the end-use category, the hospital is expected to witness higher growth.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to the rising prevalence of chronic illnesses and an increasing frequency of surgical interventions.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Elastomeric Infusion Pump Market

The elastomeric infusion pump market is evolving with new trends shaping its future. These trends reflect technological innovations, changing healthcare needs, and market dynamics.

• Integration with Digital Health Technologies: There is a growing trend toward integrating infusion pumps into digital health technologies. This may involve linking with EHRs and mobile applications to enhance monitoring, data collection, and patient management activities. Such integrations lead to improved accuracy, reduced errors, and real-time data availability for healthcare providers.
• Enhanced Safety Features: Modern elastomeric infusion pumps incorporate advanced safety features like alarms or dose error reduction systems, while others come with real-time monitoring capabilities. These innovations help reduce medication errors, improve patient safety, and ensure strict compliance with regulatory policies.
• Customization for Specific Therapies: The customization of elastomeric infusion pumps is gaining attention for specific therapeutic uses, such as chemotherapy or pain management. Tailored pumps with specialized settings and features allow for more effective control and treatment, improving control and therapeutic outcomes.
• Cost-Effective and Accessible Solutions: The market has witnessed a rise in affordable and accessible elastomeric infusion pumps, particularly in emerging economies. These solutions aim to ensure that advanced infusion technology is both available and affordable to as many patients as possible.
• Sustainability and Eco-Friendly Materials: The production of elastomeric infusion pumps is increasingly characterized by a growing preference for sustainable and eco-friendly materials. This shift addresses environmental concerns and regulatory requirements, minimizing the ecological impact of medical devices.

These emerging trends are reshaping the elastomeric infusion pump market by driving technological innovation, enhancing patient experience, and adapting to new healthcare environments. The focus on digital integration, patient-centric designs, and home healthcare reflects a shift toward more personalized and efficient treatment solutions, while regulatory scrutiny and sustainability initiatives highlight the industry's commitment to safety and environmental responsibility.

Recent Developments in the Elastomeric Infusion Pump Market

The elastomeric infusion pump market is undergoing notable developments, reflecting advancements in technology and shifts in healthcare needs. These developments are influencing market dynamics and setting new standards for infusion pump solutions.

• Integration of Smart Technologies: Recent designs of elastomeric infusion pumps have integrated connectivity with electronic health records (EHRs) and mobile apps. This innovation enables real-time monitoring and data sharing, improving drug delivery accuracy and enhancing patient management through seamless communication between devices and healthcare providers.
• Focus on Safety Enhancements: Improved versions of elastomeric infusion pumps are now fitted with more sophisticated safety mechanisms, including dose error reduction systems, malfunction detection alarms, and improved visual and auditory alerts. These enhancements help reduce medication errors, ensure patient safety, and meet higher regulatory standards by fulfilling healthcare providers' requirements for reliable devices.
• Development of Customized Pumps: There is an increasing trend toward developing elastomeric infusion pumps tailored for specific therapies, such as chemotherapy or pain management. These devices have individual settings, allowing for better control over their usage and improved dosing precision, which is crucial for therapeutic purposes.
• Cost Reduction and Accessibility: Recent advancements aim to make elastomeric infusion pumps more affordable and accessible, especially in developing markets. Innovations in manufacturing and material selection are designed to reduce production costs while maintaining high-quality standards, making these devices more affordable for healthcare facilities.
• Sustainability Initiatives: The market is seeing a shift toward sustainability, with new elastomeric infusion pumps being designed using eco-friendly materials and manufacturing processes. This trend responds to growing environmental concerns and regulatory pressures, aiming to reduce the environmental impact of medical devices and align with global sustainability goals.

These developments are transforming the elastomeric infusion pump market by advancing technology, adapting to regulatory changes, and expanding into new regions. Increased investment in R&D and the growth of homecare applications are driving innovation and improving accessibility, reflecting a dynamic shift toward more advanced and patient-centered solutions.

Strategic Growth Opportunities for Elastomeric Infusion Pump Market

The elastomeric infusion pump market presents several strategic growth opportunities across various applications. These opportunities are influenced by technological advancements and evolving healthcare needs.

• Technological Integration: There is a significant opportunity to integrate elastomeric infusion pumps with digital health technologies, such as EHRs and mobile apps. This integration improves data accuracy, patient monitoring capabilities, and real-time communication, leading to better outcomes and streamlined operations within the healthcare industry.
• Customization for Specific Treatments: Customizing elastomeric infusion pumps for specific treatments, such as chemotherapy or pain management, presents a major growth opportunity. Customization results in greater control over efficacy, meeting the diverse therapeutic needs in these specialized areas.
• Expansion into Emerging Markets: Expanding the availability of cost-effective elastomeric infusion pumps in emerging markets offers substantial growth opportunities. By addressing affordability and local healthcare needs, companies can increase market penetration and reach new patient populations in these regions.
• Focus on Sustainability: Embracing sustainability in the production of elastomeric infusion pumps is an emerging opportunity. This includes the use of environmentally friendly materials and manufacturing processes, which align with global environmental goals and appeal to environmentally conscious consumers and regulators.
• Enhanced Safety Features: Investing in advanced safety systems, such as dose error reduction systems and real-time monitoring, offers a strategic opportunity to meet rising standards for patient safety and device reliability. These improvements can also help differentiate products in a competitive market and address essential healthcare concerns.

These growth opportunities reflect the expanding applications of elastomeric infusion pumps in various healthcare settings. By focusing on home healthcare, chronic disease management, oncology, pediatric care, and emergency services, companies can leverage these opportunities to drive market expansion and meet diverse patient needs.

Elastomeric Infusion Pump Market Driver and Challenges

Market dynamics, patient safety concerns, regulatory issues, cost considerations, and technological advances are the principal drivers and challenges of the elastomeric infusion pump market. All these factors must be considered to navigate the complexities of the market and find ways to improve and grow.

Drivers of Market Growth:

• Technological Advancements: The evolution of digital health technologies and smart devices has created new growth opportunities. For instance, connecting pumps with EHRs and mobile apps enhances patient monitoring, making treatments more effective and personalized.
• Increasing Demand for Home Healthcare: The growing need for home healthcare services has driven demand for portable, easy-to-use elastomeric infusion pumps. These devices enable treatment outside hospital premises, minimizing hospitalization durations and increasing patient convenience.
• Focus on Patient Safety: The increasing emphasis on patient safety, coupled with efforts to reduce medication errors, is driving the development of advanced safety features in elastomeric infusion pumps. These mechanisms align with regulatory standards, thereby enhancing the quality of care.
• Growing Prevalence of Chronic Diseases: The high incidence of chronic illnesses, such as diabetes and cancer, continues to drive demand for reliable infusion systems. Elastomeric pumps are essential for delivering long-term therapies and supporting the treatment of various chronic conditions.
• Regulatory Support: The use of real-world evidence by regulatory bodies encourages innovation and market growth while maintaining high standards for medical devices. Regulatory guidelines ensure that device quality and safety are standardized.

Challenges in the Elastomeric Infusion Pump Market:

• High Costs: The cost of elastomeric infusion pumps may hinder widespread adoption, especially in price-sensitive markets. To address this, efforts should be made to manage costs and improve affordability.
• Data Security Concerns: As more integrations are made digitally, data security and patient privacy protection become significant challenges. Compliance with regulations and the implementation of robust security measures are necessary to mitigate these risks.
• Regulatory Compliance Complexity: Navigating through complex regulations, especially with varying requirements across regions, can be overwhelming. Meeting diverse standards can delay market entry and increase costs incurred during approval processes.

The elastomeric infusion pump market is driven by significant factors, such as technological advancements, increasing demand for homecare solutions, the growing prevalence of chronic diseases, regulatory support, and robust investment in R&D. However, challenges like regulatory hurdles, high production costs, and intense market competition impact market dynamics. Balancing these drivers and challenges is crucial for market players to drive growth, enhance product offerings, and navigate the evolving landscape of healthcare delivery.

List of Elastomeric Infusion Pump Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies elastomeric infusion pump companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the elastomeric infusion pump companies profiled in this report include-

• Ambu
• Avanos Medical
• Baxter
• B. Braun Melsungen
• Werfenlife
• Nipro
• Woo Young Medical
• Epic Medical
• Daiken Medical
• Smiths Medical

Elastomeric Infusion Pump by Segment

The study includes a forecast for the global elastomeric infusion pump by product type, end use, application, and region.

Elastomeric Infusion Pump Market by Product Type [Analysis by Value from 2018 to 2030]:

• Continuous Rate Elastomeric Infusion Pump
• Variable Rate Elastomeric Infusion Pump

Elastomeric Infusion Pump Market by End Use [Analysis by Value from 2018 to 2030]:

• Hospitals
• Ambulatory Surgical Centers
• Others

Elastomeric Infusion Pump Market by Application [Analysis by Value from 2018 to 2030]:

• Pain Management
• Chemotherapy
• Chelation Therapy
• Others

Elastomeric Infusion Pump Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Elastomeric Infusion Pump Market

The elastomeric infusion pump market has seen significant advancements across various regions due to technological innovations and increasing healthcare demands. These pumps are favored for their portability, ease of use, and cost-effectiveness in delivering medications. Recent developments reflect a global trend toward improved patient care and operational efficiency in healthcare settings.

• United States: Innovations in user-friendly designs and integration with digital health technologies are among the recent developments in the U.S. elastomeric infusion pump market. Notable advancements include improved precision in drug delivery, including smart systems to enhance patient outcomes and operational efficiency. These improvements target the growing demand for effective pain management and chemotherapy delivery.
• China: The Chinese market for elastomeric infusion pumps is expanding due to increased manufacturing capabilities and cost-effectiveness. Local production, integrated with international standards, helps cut costs while maintaining quality. Recent developments include the introduction of advanced infusion pumps tailored to local healthcare needs, making them more affordable and accessible for a broader population.
• Germany: In Germany, major developments in elastomeric infusion pumps focus on meeting regulatory compliance requirements and incorporating innovative features such as enhanced safety mechanisms and more accurate dosage controls. The market is seeing an increasing number of high-quality devices that meet strict European medical device regulations, which cater to the sophisticated healthcare system in the country.
• India: Elastomeric infusion pumps are gaining popularity in India, where they are becoming more affordable for people who need them most. Current trends focus on providing cost-effective solutions and adapting the devices to local healthcare requirements. Innovations are aimed at increasing the use of elastomeric pumps across both urban and rural areas, addressing the needs of diverse patient populations.
• Japan: In Japan, recent developments include the creation of highly accurate and reliable elastomeric infusion pumps, with features customized to meet the needs of the Japanese healthcare system. Notable innovations include integration with electronic health records (EHRs) and improved usability for healthcare providers. These advancements reflect Japan's focus on technology and precision in medical equipment.

Features of the Global Elastomeric Infusion Pump Market

Market Size Estimates: Elastomeric infusion pump market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Elastomeric infusion pump market size by product type, end use, application, and region in terms of value ($B).

Regional Analysis: Elastomeric infusion pump market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product type, end use, application, and regions for the elastomeric infusion pump market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the elastomeric infusion pump market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the elastomeric infusion pump market by product type (continuous rate elastomeric infusion pump and variable rate elastomeric infusion pump), end use (hospitals, ambulatory surgical centers, and others), application (pain management, chemotherapy, chelation therapy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Elastomeric Infusion Pump Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Elastomeric Infusion Pump Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Elastomeric Infusion Pump Market by Product Type
  • 3.3.1: Continuous Rate Elastomeric Infusion Pump
  • 3.3.2: Variable Rate Elastomeric Infusion Pump
• 3.4: Global Elastomeric Infusion Pump Market by End Use
  • 3.4.1: Hospitals
  • 3.4.2: Ambulatory Surgical Centers
  • 3.4.3: Others
• 3.5: Global Elastomeric Infusion Pump Market by Application
  • 3.5.1: Pain Management
  • 3.5.2: Chemotherapy
  • 3.5.3: Chelation Therapy
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Elastomeric Infusion Pump Market by Region
• 4.2: North American Elastomeric Infusion Pump Market
  • 4.2.1: North American Market by End Use: Hospitals, Ambulatory Surgical Centers, and Others
  • 4.2.2: North American Market by Application: Pain Management, Chemotherapy, Chelation Therapy, and Others
• 4.3: European Elastomeric Infusion Pump Market
  • 4.3.1: European Market by End Use: Hospitals, Ambulatory Surgical Centers, and Others
  • 4.3.2: European Market by Application: Pain Management, Chemotherapy, Chelation Therapy, and Others
• 4.4: APAC Elastomeric Infusion Pump Market
  • 4.4.1: APAC Market by End Use: Hospitals, Ambulatory Surgical Centers, and Others
  • 4.4.2: APAC Market by Application: Pain Management, Chemotherapy, Chelation Therapy, and Others
• 4.5: ROW Elastomeric Infusion Pump Market
  • 4.5.1: ROW Market by End Use: Hospitals, Ambulatory Surgical Centers, and Others
  • 4.5.2: ROW Market by Application: Pain Management, Chemotherapy, Chelation Therapy, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Elastomeric Infusion Pump Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Elastomeric Infusion Pump Market by End Use
  • 6.1.3: Growth Opportunities for the Global Elastomeric Infusion Pump Market by Application
  • 6.1.4: Growth Opportunities for the Global Elastomeric Infusion Pump Market by Region
• 6.2: Emerging Trends in the Global Elastomeric Infusion Pump Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Elastomeric Infusion Pump Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Elastomeric Infusion Pump Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Ambu
• 7.2: Avanos Medical
• 7.3: Baxter
• 7.4: B. Braun Melsungen
• 7.5: Werfenlife
• 7.6: Nipro
• 7.7: Woo Young Medical
• 7.8: Epic Medical
• 7.9: Daiken Medical
• 7.10: Smiths Medical